RECARBRIO

What is this medication? Recarbrio is a prescription combination medicine that contains three active ingredients: imipenem, cilastatin, and relebactam. Imipenem is a carbapenem antibiotic that kills bacteria, while cilastatin prevents the breakdown of imipenem in the kidneys to ensure the antibiotic stays effective longer. Relebactam is a beta-lactamase inhibitor that helps protect the antibiotic from being destroyed by certain enzymes produced by resistant bacteria. This injectable medication is typically administered by a healthcare professional in a hospital or clinic setting via an intravenous infusion.

This medication is specifically used to treat adults with serious bacterial infections caused by susceptible gram-negative organisms. It is indicated for the treatment of complicated urinary tract infections, including a type of kidney infection called pyelonephritis, and complicated intra-abdominal infections. Additionally, it is used for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Doctors usually prescribe Recarbrio when other treatment options are limited or not suitable for the patient's specific infection.